(Q46268724)

20 December 2017

title

Dasatinib-induced restoration of donor chimerism in BCR-ABL1-positive ALL after failure of imatinib therapy and allo-SCT. (English)

1 reference

20 December 2017

1 reference

A Quintás-Cardama

1

1 reference

20 December 2017

J Cortes

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

3 November 2008

1 reference

20 December 2017

Bone Marrow Transplantation

published in

1 reference

20 December 2017

volume

43

1 reference

20 December 2017

issue

7

1 reference

20 December 2017

page(s)

579-581

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2008.354

exact match

0 references

cites work

Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

Overriding imatinib resistance with a novel ABL kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

inferred from DOI database lookup

7 January 2021

based on heuristic

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

inferred from DOI database lookup

7 January 2021

based on heuristic

Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.354

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/BMT.2008.354

1 reference

20 December 2017

1 reference

20 December 2017